Follow
Remi Rosiere
Title
Cited by
Cited by
Year
Formulations for intranasal delivery of pharmacological agents to combat brain disease: a new opportunity to tackle GBM?
M Van Woensel, N Wauthoz, R Rosière, K Amighi, V Mathieu, F Lefranc, ...
Cancers 5 (3), 1020-1048, 2013
1742013
Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
M Van Woensel, N Wauthoz, R Rosière, V Mathieu, R Kiss, F Lefranc, ...
Journal of Controlled Release 227, 71-81, 2016
1502016
Sensitization of glioblastoma tumor micro-environment to chemo-and immunotherapy by Galectin-1 intranasal knock-down strategy
M Van Woensel, T Mathivet, N Wauthoz, R Rosière, AD Garg, P Agostinis, ...
Scientific Reports 7 (1), 1217, 2017
1252017
New co‐spray‐dried tobramycin nanoparticles–clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients
G Pilcer, R Rosière, K Traina, T Sebti, F Vanderbist, K Amighi
Journal of pharmaceutical sciences 102 (6), 1836-1846, 2013
612013
Development of controlled-release cisplatin dry powders for inhalation against lung cancers
V Levet, R Rosière, R Merlos, L Fusaro, G Berger, K Amighi, N Wauthoz
International Journal of Pharmaceutics 515 (1), 209-220, 2016
572016
Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy
R Rosière, M Van Woensel, V Mathieu, I Langer, T Mathivet, ...
International journal of pharmaceutics 501 (1), 148-159, 2016
412016
New dry powders for inhalation containing temozolomide-based nanomicelles for improved lung cancer therapy
R Rosière, M Gelbcke, V Mathieu, P Van Antwerpen, K Amighi, ...
International journal of oncology 47 (3), 1131-1142, 2015
242015
Platinum pharmacokinetics in mice following inhalation of cisplatin dry powders with different release and lung retention properties
V Levet, R Merlos, R Rosière, K Amighi, N Wauthoz
International Journal of Pharmaceutics 517 (1), 359-372, 2017
232017
Formulations Useful in the Treatment of Proliferative Diseases Affecting the Respiratory Tract
K Amighi, R Rosiére, N Wauthoz, M Gelbecke
US Patent App. 15/029,736, 2014
18*2014
New Dry Powders for Inhalation containing Chitosan Derivative-coated Solid Lipid Nanoparticles for Targeted Delivery to Lung Cancer Cells
R Rosiere, K Amighi, M VERMEERSCH, N WAUTHOZ
RDD Europe 2015, 447-452, 2015
92015
New lung-tumour-penetrating nanocarrier designed for aerosolized chemotherapy
R Rosière, M Van Woensel, V Mathieu, T Mathivet, K Amighi, N Wauthoz
2*
Development of Folate Receptor-Targeted Nanoparticles Containing Temozolomide for Lung Cancers Therapy by Dry Powder Inhalation
R Rosiere, N Wauthoz, P Van Antwerpen, M Gelbcke, K Amighi, R Dalby, ...
Respiratory Drug Delivery 2014. Volume 3, 2014
12014
LOCAL AND SYSTEMIC PHARMACOKINETIC EVALUATION OF IMMEDIATE-RELEASE AND CONTROLLED-RELEASE CISPLATIN DRY POWDERS FOR INHALATION AGAINST LUNG CANCER
V Levet, R Rosiere, K Amighi, N Wauthoz
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY 30 (4), A8-A9, 2017
2017
Abstracts from The Aerosol Society Drug Delivery to the Lungs 27 Edinburgh International Conference Centre Edinburgh, Scotland, UK December 7–9, 2016
SP Newman, I Sibum, F Grasmeijer, P Hagedoorn, HW Frijlink, N Alizoti, ...
Journal of Aerosol Medicine and Pulmonary Drug Delivery 30 (4), A-1-A-30, 2017
2017
DEVELOPMENT OF DRY POWDER FORMULATIONS FOR INHALATION BASED ON NANOMEDICINE FOR TARGETED LUNG CANCER THERAPY
R Rosiere, K Amighi
Université libre de Bruxelles, 2016
2016
Intranasal delivery of anti-Galectin-1 formulation to increase the efficiency of chemo-and immunotherapy for glioblastoma
M van Woensel, N Wauthoz, R Rosiere, K Amighi, V Mathieu, F Lefranc, ...
2014
Development of New Inhalable Formulations for the Lung Cancers Therapy
R Rosiere, N Wauthoz, M Gelbcke, P Van Antwerpen, K Amighi
2013
The system can't perform the operation now. Try again later.
Articles 1–17